Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of Matrix Rhythm Therapy for Restless Legs Syndrome

NCT: NCT07561476 · COMPLETED

NCT IDNCT07561476
StatusCOMPLETED
Start Date2021-05-04
Completion2022-09-21

Brief Summary

The goal of this clinical trial is to evaluate whether Matrix Rhythm Therapy (MRT), when added to a home exercise program, is effective in reducing symptoms of Restless Legs Syndrome (RLS) in adult women. It will also examine the effects of treatment on sleep quality, daytime sleepiness, depressive symptoms, and quality of life. The main questions it aims to answer are: Does Matrix Rhythm Therapy reduce the severity of Restless Legs Syndrome symptoms? Does Matrix Rhythm Therapy improve sleep quality and insomnia symptoms? Does Matrix Rhythm Therapy improve quality of life and emotional well-being? Researchers compared participants receiving Matrix Rhythm Therapy plus home exercise with participants receiving home exercise alone. Participants will: Be randomly assigned to one of two study groups Receive a home exercise program for 5 weeks Receive Matrix Rhythm Therapy sessions twice weekly for 5 weeks if assigned to the intervention group Complete questionnaires and clinical assessments before and after treatment

Frequently Asked Questions

What is Effectiveness of Matrix Rhythm Therapy for Restless Legs Syndrome?

Effectiveness of Matrix Rhythm Therapy for Restless Legs Syndrome is a clinical trial registered under NCT07561476. Current status: COMPLETED.

What is the status of NCT07561476?

The current status of NCT07561476 (Effectiveness of Matrix Rhythm Therapy for Restless Legs Syndrome) is: COMPLETED.

When did Effectiveness of Matrix Rhythm Therapy for Restless Legs Syndrome start?

Effectiveness of Matrix Rhythm Therapy for Restless Legs Syndrome started on 2021-05-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.